InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.25
(
0.20%
)
US TECH 100
18,971.20
(
-0.03%
)
Dow Jones
40,659.76
(
0.24%
)
Brent Oil
79.17
(
0.00%
)
Bitcoin
59,403.70
(
0.89%
)
Post# of 346200
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

md1225

Send PM Follow Ignore
Followers 98
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

md1225

Re: Couch post# 254857

Friday, 02/26/2016 9:57:49 AM

Friday, February 26, 2016 9:57:49 AM

Post# of 346200
As Djohn posted bavituximab is alive and well only our flagship trial is halted.

Now go it alone is over. Partner they know they must or sell.

As I said earlier MSK AZN and NCCN did not care if a P3 trial was running. They partnered because of the combo PD1 data in hand.

Now the have more data showing bavituximab was trending as hoped!

Chemo combos is not the future of lung cancer we all knew this. Its fiscally responsible to stop SUNRISE and move right to durvalumab AZN trial.

Painful to watch I want to buy more but I will just hold and wait for partnership announcement.

If bavituximab truly allows PD1 negative patients to receive durvalumab then AZN will buy us out and not for 200m either.

Bavituximab the essential key to a cure for cancer needed by all pharmaceutical companies.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM

Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM

POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM

Start posting your company's news
Only $200 per official company press release!